Patents expiring in 2036

US 9416139

Spiro ring compound as hepatitis C virus (HCV) inhibitor and uses thereof

SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9416162

Peptides having reduced toxicity that stimulate cholesterol efflux

The Regents of the University of California · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9415123

Polymeric nanoparticles for ultrasound imaging and therapy

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9416112

2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9421275

Oligomer-calcimimetic conjugates and related compunds

Nektar Therapeutics · Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9422245

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC · Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9422260

Process for the synthesis of 4,5,6,7-tetrachloro-3′,6′-dihydroxy-2′,4′,5′,7′-tetraiodo-3H-spiro[isobenzofuran-1,9′-xanthen]-3-one(Rose Bengal) and related xanthenes

Provectus Pharmatech, Inc. · Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9422318

Epoxyeicosatrienoic acid analogs and methods of making and using the same

The Board of Regents of the University of Texas System · Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9422310

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9422327

Process for preparing crystalline ciclesonide with defined particle size

TAKEDA GMBH · Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9422352

PTD-SMAD7 therapeutics

The Regents of the University of Colorado, a Body Corporate · Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9422365

Peptide or arrangement of peptides forming a Staphylococcus aureus epitope binding site

Julius-Maximilians-Universitat Wurzburg · Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9422529

Alphavirus compositions and methods of use

The Board of Regents of the University of Texas System · Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9422347

Algal produced malarial transmission blocking vaccines

The Regents of the University of California · Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9422562

Compositions and methods for inhibiting expression of CD274/PD-L1 gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9422339

Immunomodulating cyclic compounds

Aurigene Discovery Technologies Limited · Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9421196

Amides as modulators of sodium channels

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9421169

Oral dosage forms for delivery of therapeutic agents

Covidien LP · Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9420821

Drinking water formulation and method and article relating to same

ESSENTIALIFE HOMEOPATHICS · Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9422556

RNAi-related inhibition of TNF-alpha signaling pathway for treatment of ocular angiogenesis

Arrowhead Pharmaceuticals, Inc. · Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9422522

Method of producing adipocytes from fibroblast cells

Regenertech Pty Limited · Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9422413

Elastomer formulations comprising discrete carbon nanotube fibers

MOLECULAR REBAR DESIGN, LLC · Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9422340

Macrocyclic compounds useful as inhibitors of histone deacetylases

The Regents of the University of Colorado, a Body Corporate · Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9422271

Pyrimidine compounds as tuberculosis inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9421254

Immunostimulatory combinations of TLR ligands and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9421240

Compstatin analogs for treatment of neuropathic pain

Apellis Pharmaceuticals, Inc. · Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9421185

Diagnosis and treatment methods for entry of gastrointestinal contents into respiratory tract

The Regents of the University of California · Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9422223

Compounds and methods for delivery of prostacyclin analogs

United Therapeutics Corporation · Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9421194

Lung targeting dual drug delivery system

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9421204

Oligomer modified diaromatic substituted compounds

Nektar Therapeutics · Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9421250

Pathogenic phlebovirus isolates and compositions and methods of use

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9421241

Therapeutic modulation of ocular surface lubrication

The Regents of the University of California · Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 2977090

FORMULATIONS PHARMACEUTIQUES DE L'INHIBITEUR D'ESTERASE C1

CSL BEHRING GMBH [DE] · Granted Thu Aug 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Aug 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9427578

Pharmacokinetics of iontophoretic sumatriptan administration

TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Tue Aug 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9427422

Compositions for treating cardiovascular diseases

Infirst Healthcare Limited · Granted Tue Aug 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9428749

Control of whole body energy homeostasis by microRNA regulation

The Board of Regents of the University of Texas System · Granted Tue Aug 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9428541

Substrate reduction therapy

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9427447

Anti-viral pyrimidine nucleoside derivatives

University College Cardiff Consultants Limited · Granted Tue Aug 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9427410

Formulation of acoustically activatable particles having low vaporization energy and methods for using same

Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Aug 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9428470

Heterocyclic compound

Takeda Pharmaceutical Company Limited · Granted Tue Aug 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9427434

Coated preparation

Takeda Pharmaceutical Company Limited · Granted Tue Aug 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9428467

Selective calcium channel antagonists

Northwestern University · Granted Tue Aug 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9427381

Dental curable composition, and method for producing same

KURARAY NORITAKE DENTAL INC. · Granted Tue Aug 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9427423

Fatty-acid based particles

ATRIUM MEDICAL CORPORATION · Granted Tue Aug 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9427476

Multivalent meningococcal conjugates and methods for preparing conjugates

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9427469

Soluble physiological chitosan formulations combined with platelet-rich plasma (PRP) for tissue repair

ORTHO REGENERATIVE TECHNOLOGIES INC. · Granted Tue Aug 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9427472

Controlled release compositions for modulating free-radical induced damage and methods of use thereof

The Regents of the University of California · Granted Tue Aug 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9428457

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC · Granted Tue Aug 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)